| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| SEVREDOL 10 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59252001 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 10 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59252002 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 10 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59252003 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 20 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59251001 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 20 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59251002 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 20 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59251003 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SHINGRIX | VACCIN VARICELO-ZOSTERIAN (RECOMBINANT, CU ADJUVANT) | PULB.+SUSP. PT. SUSP. INJ. | J07BK03 | W71013001 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | X | |||||
| SHINGRIX | VACCIN VARICELO-ZOSTERIAN (RECOMBINANT, CU ADJUVANT) | PULB.+SUSP. PT. SUSP. INJ. | J07BK03 | W71013002 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | X | |||||
| SIALANAR 320 micrograme/ml | GLICOPIRONIUM BROMIDUM | SOL. ORALA | A03AB02 | W69128001 | PROVECA PHARMA LIMITED - IRLANDA | X | |||||
| SIALANAR 320 micrograme/ml | GLICOPIRONIUM BROMIDUM | SOL. ORALA | A03AB02 | W69128002 | PROVECA PHARMA LIMITED - IRLANDA | X | |||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202001 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202002 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202003 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202004 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202005 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 150 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70203001 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 150 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70203002 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 150 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70203003 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 150 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70203004 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 150 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70203005 | EGIS PHARMACEUTICALS PLC. - UNGARIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman